Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEG-Intron for Plexiform Neurofibromas
NCT00396019Phase 2Completed
- Sponsor
- University of Pittsburgh
- Start
- Dec 2006
- Primary completion
- Apr 2014
- Modality
- Polymer-based Nanoparticles, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of peginterferon alfa-2b in plexiform neurofibroma (PN), sponsored by University of Pittsburgh. Started Dec 2006; status: completed.
02
Drugs
peginterferon alfa-2b
03
Conditions
plexiform neurofibroma (PN)
Beyond the preview
Go deeper on NCT00396019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00396019.